Non-melanoma skin cancers, including cSCC and BCC, show elevated Th1 and Th17 cells compared to normal skin, increased IFN-γ-producing CD8+ T cells, and decreased γδ T cells [42,65]. This evidence concerns the gene IFNG and skin basal cell carcinoma.